Hematopoietic stem cell and progenitor defects in Sca-1/Ly-6A-null mice

Blood

Volumn 101, Issue 2, 2003, Pages 517-523

  Ito, Caryn Y ^a,b   Li, Carol Y J ^a,b   Bernstein, Alan ^a,b   Dick, John E ^a,b   Stanford, William L ^a,b,c  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CELL MARKER; SCA 1 ANTIGEN; UNCLASSIFIED DRUG;

ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CELL DIFFERENTIATION; CELL POPULATION; CELL RENEWAL; COLONY FORMING UNIT; CONTROLLED STUDY; ERYTHROID CELL; GRANULOCYTE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IRRADIATION; MACROPHAGE; MEGAKARYOCYTE; MOUSE; NONHUMAN; NULL ALLELE; PRIORITY JOURNAL; STEM CELL; T LYMPHOCYTE; THROMBOCYTE; THROMBOCYTOPENIA;

EID: 0037438686     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-06-1918     Document Type: Article

References (43)

1. Osawa M, Hanada K, Hamada H, Nakauchi H. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science. 1996;273:242-245.
2. Zhao Y, Lin Y, Zhan Y, et al. Murine hematopoietic stem cell characterization and its regulation in BM transplantation. Blood. 2000;96:3016-3022.
3. Kondo M, Weissman IL, Akashi K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell. 1997;91:661-672.
4. Spangrude GJ, Klein J, Heimfeld S, Aihara Y, Weissman IL. Two monoclonal antibodies identify thymic-repopulating cells in mouse bone marrow. J Immunol. 1989;142:425-430.
5. Bamezal A, Palliser D, Berezovskaya A, et al. Regulated expression of Ly-6A.2 is important for T cell development. J Immunol. 1995;154:4233-4239.
6. Akashi K, Traver D, Miyamoto T, Weissman IL. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 2000;404: 193-197.
7. Trevisan M, Iscove NN. Phenotypic analysis of murine long-term hemopoietic reconstituting cells quantitated competitively in vivo and comparison with more advanced colony-forming progeny. J Exp Med. 1995;181:93-103.
8. Yotoku M, Grossberg AL, Pressman D. A cell surface antigenic determinant present on mouse plasmacytes and only half of mouse thymocytes. J Immunol. 1974;112:1774-1781.
9. Horejsi V, Drbal K, Cebecauer M, et al. GPI-microdomains: a role in signalling via immunoreceptors. Immunol Today. 1999;20:356-361.
10. Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000;1:31-39.
11. Stefanova I, Horejsi V, Ansotegui IJ, Knapp W, Stockinger H. GPI-anchored cell-surface molecules complexed to protein tyrosine kinases. Science. 1991;254:1016-1019.
12. Ninomiya H, Sims PJ. The human complement regulatory protein CD59 binds to the alpha-chain of C8 and to the "b" domain of C9. J Biol Chem. 1992;267:13675-13680.
13. Murray EW, Robbins SM. Antibody cross-linking of the glycosylphosphatidylinositol-linked protein CD59 on hematopoietic cells induces signaling pathways resembling activation by complement. J Biol Chem. 1998;273:25279-25284.
14. English A, Kosoy R, Pawlinski R, Bamezai A. A monoclonal antibody against the 66-kDa protein in mouse spleen and thymus inhibits Ly-6A.2dependent cell-cell adhesion. J Immunol. 2000; 165:3763-3771.
15. Malek TR, Ortega G, Chan C, Kroczek RA, Shevach EM. Role of Ly-6 in lymphocyte activation, II: induction of T cell activation by monoclonal anti-Ly-6 antibodies. J Exp Med. 1986;164:709-722.
16. Rock KL, Yeh ET, Gramm CF, Haber SI, Reiser H, Benacerraf B. TAP, a novel T cell-activating protein involved in the stimulation of MHC-restricted T lymphocytes. J Exp Med. 1986;163:315-333.
17. Codias EK, Rutter JE, Fleming TJ, Malek TR. Down-regulation of IL-2 production by activation of T cells through Ly-6A/E. J Immunol. 1990;145: 1407-1414.
18. Marmor MD, Bachmann MF, Ohashi PS, Malek TR, Julius M. Immobilization of glycosylphosphatidylinositol-anchored proteins inhibits T cell growth but not function. Int Immunol. 1999;11: 1381-1393.
19. Stanford WL, Haque S, Alexander R, et al. Altered proliferative response by T lymphocytes of Ly-6A (Sca-1) null mice. J Exp Med. 1997;186: 705-717.
20. Henderson SC, Kamdar MM, Bamezai A. Ly-6A.2 expression regulates antigen-specific CD4+ T cell proliferation and cytokine production. J Immunol. 2002;168:118-126.
21. Zhang Z-X, Stanford WL, Zhang L. Ly-6A is critical for double negative T cell-mediated antigenspecific regulation. Eur J Immunol. 2002;32: 1584-1592.
22. Nagy A, Rossant J. Production of completely ES cell derived fetuses. In: Joyner A, ed. Gene Targeting: A Practical Approach. New York, NY: IRL Press; 1993:147-179.
23. Chabot B, Stephenson DA, Chapman VM, Besmer P, Bernstein A. The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature. 1988;335: 88-89.
24. Nocka K, Tan JC, Chiu E, et al. Molecular bases of dominant negative and loss of function mutations at the murine c-kit/white spotting locus: W37, Wv, W41 and W. EMBO J. 1990;9:1805-1813.
25. Dumont FJ, Coker LZ. Interferon-alpha/beta enhances the expression of Ly-6A antigens on T cells in vivo and in vitro. Eur J Immunol. 1986;16: 735-740.
26. Dumont FJ, Dijkmans R, Palfree RGE, Boltz RD, Coker LZ. Selective up-regulation by interferongamma of surface molecules of the Ly-6 complex on resting T cells: the Ly-6A/E and TAP antigens are preferentially enhanced. Eur J Immunol. 1987;17:1183-1191.
27. Malek TR, Danis KM, Codias EK. Tumor necrosis factor synergistically acts with IFN-gamma to regulate Ly-6A/E expression in T lymphocytes, thymocytes and bone marrow cells. J Immunol. 1989;142:1929-1936.
28. Russell ES. Hereditary anemias of the mouse: a review for geneticists. Adv Genet. 1979;20:357-459.
29. Ebbe S, Carpenter D, Yee T. Megakaryocytopenia in W/Wv mice is accompanied by an increase in size within ploidy groups and acceleration of maturation. Blood. 1989;74:94-98.
30. Lowell CA, Soriano P. Knockouts of Src-family kinases: stiff bones, wimpy T cells, and bad memories. Genes Dev. 1996;10:1845-1857.
31. Lancki DW, Qian D, Fields P, Gajewski T, Fitch FW. Differential requirements for protein tyrosine kinase Fyn in the functional activation of antigenspecific T lymphocyte clones through the TCR or Thy-1. J Immunol. 1995;154:4363-4370.
32. Broudy VC, Lin NL, Liles WC, et al. Signaling via Src family kinases is required for normal internalization of the receptor c-Kit. Blood. 1999;94:1979-1986.
33. Takeda J, Miyata T, Kawagoe K, et al. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell. 1993;73:703-711.
34. Sun X, Funk CD, Deng C, Sahu A, Lambris JD, Song WC. Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting. Proc Natl Acad Sci U S A. 1999;96:628-633.
35. Holt DS, Botto M, Bygrave AE, Hanna SM, Walport MJ, Morgan BP. Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria. Blood. 2001;98: 442-449.
36. Araten DJ, Nafa K, Pakdeesuwan K, Luzzatto L. Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals. Proc Natl Acad Sci U S A. 1999;96:5209-5214.
37. Rosti V, Tremml G, Soares V, Pandolfi PP, Luzzatto L, Bessler M. Murine embryonic stem cells without pig-a gene activity are competent for hematopoiesis with the PNH phenotype but not for clonal expansion. J Clin Invest. 1997;100:1028-1036.
38. Gussoni E, Soneoka Y, Strickland CD, et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature. 1999;401:390-394.
39. Lee JY, Qu-Petersen Z, Cao B, et al. Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. J Cell Biol. 2000;150:1085-1100.
40. Welm BE, Tepera SB, Venezia T, Graubert TA, Rosen JM, Goodell MA. Sca-1 (pos) cells in the mouse mammary gland represent an enriched progenitor cell population. Dev Biol. 2002; 245:42-56.
41. Short B, Brouard N, Occhiodoro-Scott T, Simmons PJ. Prospective isolation of stromal stem cells from mouse compact bone. Keystone Symposium on Stem Cells: Origin, Fates and Functions. March 17-23. 2002:99 (abstract 411).
42. Zandstra PW, Lauffenburger DA, Eaves CJ. A ligand-receptor signaling threshold model of stem cell differentiation control: a biologically conserved mechanism applicable to hematopoiesis. Blood. 2000;96:1215-1222.
43. Viswanathan S, Benatar T, Rose-John S, Lauffenburger DA, Zandstra PW. Ligand/receptor signaling threshold (LIST) model accounts for gp130-mediated embryonic stem cell self-renewal responses to LIF and HIL-6. Stem Cells. 2002;20: 119-138.